April 05, 2021
The Ninth Circuit on Friday revived allegations from a whistleblower's suit that Medtronic fraudulently obtained U.S. Food and Drug Administration clearance for certain spinal surgery implants, but affirmed the dismissal of other claims alleging the medical device maker offered kickbacks to health care providers and pushed off-label uses of the devices.
February 10, 2021
The company behind False Claims Act allegations accusing Medtronic of fraudulently obtaining U.S. Food and Drug Administration clearance for a spinal surgery device and offering kickbacks to health care providers urged the Ninth Circuit on Wednesday to revive the suit, saying discovery is needed to get a clearer picture of the alleged wrongdoing.